Roesrath, Germany

Jean-Marie Viktor De Vry


Average Co-Inventor Count = 8.3

ph-index = 3

Forward Citations = 31(Granted Patents)


Location History:

  • Roesrath, DE (1994 - 1996)
  • Rosrath, DE (1997)

Company Filing History:


Years Active: 1994-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Marie Viktor De Vry

Introduction

Jean-Marie Viktor De Vry is a notable inventor based in Roesrath, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic applications. With a total of 3 patents to his name, De Vry's work has the potential to impact various medical treatments.

Latest Patents

One of his latest patents involves substituted 4-phenyl-6-amino-nicotinic acid compounds. This application relates to the use of these derivatives for therapeutic purposes, focusing on their role as cerebrally active agents. The active compounds are synthesized through the oxidation of appropriately substituted dihydropyridines using established methods. Another significant patent pertains to substituted aminomethyltetralins and their heterocyclic analogues. This patent outlines a method for treating stroke in patients by administering a specific substituted aminomethylchroman compound.

Career Highlights

Jean-Marie Viktor De Vry is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His work at Bayer has allowed him to explore innovative solutions in drug development and therapeutic applications. His contributions have been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, De Vry has collaborated with esteemed colleagues such as Bodo Junge and Thomas Glaser. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of medicinal chemistry.

Conclusion

Jean-Marie Viktor De Vry's innovative work in the field of medicinal chemistry highlights his commitment to advancing therapeutic solutions. His patents reflect a dedication to improving patient outcomes through scientific research and collaboration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…